Cite
HARVARD Citation
Sricharoenchai, S. et al. (2018). A genetically inactivated two-component acellular pertussis vaccine, alone or combined with tetanus and reduced-dose diphtheria vaccines, in adolescents: a phase 2/3, randomised controlled non-inferiority trial. Lancet infectious diseases. 18 (1), pp. 58-67. [Online].